The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome

Author(s):
Meun, C.; Gunning, M.N.; Louwers, Y.V.; Peters, H.; Roos-Hesselink, J.; Lennep, J.R. van; Ochoa, O.L.R.; Appelman, Y.; Lambalk, N.; Boersma, E.; Kavousi, M.; Fauser, B.C.J.M.; Laven, J.S.E.; Baart, S.; Benschop, L.; Brouwers, L.; Budde, R.; Cannegieter, S.; Dam, V.; Eijkemans, R.; Fauser, B.; Ferrari, M.; Franx, A.; Groot, C. de; Gunning, M.; Hoek, A.; Koffijberg, E.; Koster, W.; Kruit, M.; Lagerweij, G.; Laven, J.; Linstra, K.; Lugt, A. van der; Maas, A.; Brink, A.M. van den; Middeldorp, S.; Moons, K.G.M.; Rijn, B. van; Scheres, L.; Schouw, Y.T. van der; Steegers, E.; Steegers, R.; Terwindt, G.; Velthuis, B.; Wermer, M.; Zick, B.; Zoet, G.; CREW Consortium
Published
2019
Publication type
Article / Letter to editor
cardiovascular disease (7)polycystic ovary syndrome
Date issued
2019-11-24
Language
English
Is part of
Clinical Endocrinology
hdl
1887/120641
doi
10.1111/cen.14117